SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 201.21 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 337.06 |
| Book Value / Share | 2.63 |
| Price / Book | n/a |
| NCAV ($M) | 191.42 |
| NCAV / Share | 1.49 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.13 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | -0.18 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.37 |
| Current Ratio | 4.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 262.22 |
| Assets | 407.86 |
| Liabilities | 70.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 159.84 |
| Operating Income | -35.67 |
| Net Income | -45.44 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 3.87 |
| Cash from Investing | -38.77 |
| Cash from Financing | 107.78 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | BT DE Investments Inc. | 25.80 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 282,598 | 628,724 | 44.95 | |
| 142,958 | 402,784 | 35.49 | |
| 145,706 | 663,910 | 21.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NUVL – Nuvalent, Inc. | NVAX – Novavax, Inc. |
| NXTC – NextCure, Inc. | OLMA – Olema Pharmaceuticals, Inc. |
| OMGA – Omega Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io